The SARS-CoV-2 variant: B.1.1.529 was first reported to WHO from South Africa on 24 Nov 2021, which has a large number of mutations and was named as new variant Omicron.

After bioinformatics analysis and experimental validation, Coyote Bioscience hereby declare that the detection performance of our SARS-CoV-2 detection kit is not affected by the mutation of the new variant Omicron.

We will continue to pay close attention to newly emerging variants and follow up the latest mutant information and conduct relevant analysis and validation to ensure the effectiveness of the detection system.